- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Diabetes Research
Volume 2013 (2013), Article ID 849295, 9 pages
Effects of Glucose Load and Nateglinide Intervention on Endothelial Function and Oxidative Stress
1VIP Department, Beijing Hospital of the Ministry of Health, Dongdan Dahua, Road Number One, Beijing 100730, China
2Endocrinology and Metabolism Department, Beijing Hospital of the Ministry of Health, Dongdan Dahua, Road Number One, Beijing 100730, China
3Ultrasound Division, Beijing Hospital of the Ministry of Health, Dongdan Dahua, Road Number One, Beijing 100730, China
4Laboratory Division, Beijing Hospital of the Ministry of Health, Dongdan Dahua, Road Number One, Beijing 100730, China
Received 14 November 2012; Revised 17 February 2013; Accepted 18 February 2013
Academic Editor: Weiping Jia
Copyright © 2013 Leilei Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- “Diabetes,” 2011, http://www.who.int/mediacentre/factsheets/fs312/en/index.html.
- M. Mogi and M. Horiuchi, “Neurovascular coupling in cognitive impairment associated with diabetes mellitus,” Circulation Journal, vol. 75, no. 5, pp. 1042–1048, 2011.
- S. M. Son, “Role of vascular reactive oxygen species in development of vascular abnormalities in diabetes,” Diabetes Research and Clinical Practice, vol. 77, no. 3, pp. S65–S70, 2007.
- E. M. Horváth, R. Benko, L. Kiss et al., “Rapid 'glycaemic swings' induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus,” Diabetologia, vol. 52, no. 5, pp. 952–961, 2009.
- S. Simsek, I. A. M. van den Oever, H. G. Raterman, and M. T. Nurmohamed, “Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus,” Mediators of Inflammation, vol. 2010, Article ID 792393, 15 pages, 2010.
- U. Forstermann, “Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies,” Nature Clinical Practice Cardiovascular Medicine, vol. 5, no. 6, pp. 338–349, 2008.
- A. Georgescu, “Vascular dysfunction in diabetes: the endothelial progenitor cells as new therapeutic strategy,” The World Journal of Diabetes, vol. 2, no. 6, pp. 92–97, 2011.
- L. Monnier, E. Mas, C. Ginet et al., “Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes,” Journal of the American Medical Association, vol. 295, no. 14, pp. 1681–1687, 2006.
- G. Su, S. Mi, H. Tao et al., “Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes,” Cardiovascular Diabetology, vol. 10, article 19, 2011.
- J. Y. Shin, H. R. Lee, and D. C. Lee, “Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes,” Cardiovascular Diabetology, vol. 10, article 30, 2011.
- A. Major-Pedersen, N. Ihlemann, T. S. Hermann et al., “Effects of acute and chronic attenuation of postprandial hyperglycemia on postglucose-load endothelial function in insulin resistant individuals: is stimulation of first phase insulin secretion beneficial for the endothelial function?” Hormone and Metabolic Research, vol. 40, no. 9, pp. 607–613, 2008.
- K. Watanabe, K. Oba, T. Suzuki et al., “Oral glucose loading attenuates endothelial function in normal individual,” The European Journal of Clinical Investigation, vol. 41, no. 5, pp. 465–473, 2011.
- T. Hirose, R. Mizuno, and T. Yoshimoto, “The effects of nateglinide following oral glucose load in impaired glucose tolerance subjects: rapid insulin stimulation by nateglinide in IGT subjects,” Endocrine Journal, vol. 49, no. 6, pp. 649–652, 2002.
- WHO, “Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia,” 2011, http://whqlibdoc.who.int/publications/2006/9241594934_eng.pdf.
- L. M. Title, E. Lonn, F. Charbonneau et al., “Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome,” Vascular Medicine, vol. 13, no. 4, pp. 263–270, 2008.
- A. Peretz, D. F. Leotta, J. H. Sullivan et al., “Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization,” BMC Cardiovascular Disorders, vol. 7, article 11, 2007.
- V. J. Bermúdez-Pirela, C. Cano, M. T. Medina et al., “Metformin plus low-dose glimeperide significantly improves homeostasis model assessment for insulin resistance (HOMAIR) and β-cell function (HOMAβ-cell) without hyperinsulinemia in patients with type 2 diabetes mellitus,” The American Journal of Therapeutics, vol. 14, no. 2, pp. 194–202, 2007.
- L. Zhu, X. Li, G. Wnag, et al., “Seven-year follow-up study of relationship between endothelial function and risk factors of cardiovascular diseases in obese subjects,” The Chinese Preventive Medicine, vol. 10, no. 12, pp. 1057–1059, 2009.
- A. E. Caballero, K. Bousquet-Santos, L. Robles-Osorio et al., “Overweight latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance,” Diabetes Care, vol. 31, no. 3, pp. 576–582, 2008.
- C. Gersch, S. P. Palii, K. M. Kim, A. Angerhofer, R. J. Johnson, and G. N. Henderson, “Inactivation of nitric oxide by uric acid,” Nucleosides, Nucleotides and Nucleic Acids, vol. 27, no. 8, pp. 967–978, 2008.
- W. Wang, Z. Xie, A. Yne, et al., “The analysis of oxidative stress state and its influencing factors in 92 patients with type 2 diabetes,” The Chinese Journal of Diabetes, vol. 15, no. 8, pp. 487–489, 2007.
- H. M. Mattern and C. D. Hardin, “Vascular metabolic dysfunction and lipotoxicity,” Physiological Research, vol. 56, no. 2, pp. 149–158, 2007.
- C. Jin and Y. Gao, “Relationship between endothelial function of brachial artery and carotid IMT in hypertention and diabetes mellitus,” Modern Preventive Medicine, vol. 36, no. 24, pp. 4679–4681, 2009.
- Z. Zhang, X. Chen, W. Jiang, et al., “Studys of the Intima medial thickness and vascular endothelial function of in patients with newly diagnosed diabetic mellitus,” The Chinese Journal of Health, vol. 11, no. 5, pp. 451–453, 2008.
- A. Imamura, R. Takahashi, R. Murakami et al., “The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: the significance of plasma adiponectin levels,” The European Journal of Endocrinology, vol. 158, no. 2, pp. 189–195, 2008.
- Z. Tang, S. Peng, and H. Yang, “Analysis of plasma endothelin, nitric oxide, C reactive protein level in patients with impaired glucose tolerance,” Journal of Chinese Practical Diagnosis and Therapy, vol. 23, no. 1, pp. 75–76, 2009.
- G. D. Xiang, H. L. Sun, L. S. Zhao, J. Hou, L. Yue, and L. Xu, “The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance,” Clinical Endocrinology, vol. 68, no. 5, pp. 716–723, 2008.
- Q. Zhang, S. Yan, X. Liu, et al., “Changes of vascular endothelial function and sP-selectin in patients with different glucose intolerance,” The Chinese Journal of Diabetes, vol. 16, no. 2, pp. 101–103, 2008.
- Y. Kang and J. Lu, “Study of correlation between oxidative stress activation, pancreatic islet function and acute glycemic excursion in subtypes of impaired glucose regulation,” The Chinese Journal of Diabetes, vol. 1, no. 1, pp. 19–24, 2009.
- J. B. Meigs, M. G. Larson, C. S. Fox, J. F. Keaney, R. S. Vasan, and E. J. Benjamin, “Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study,” Diabetes Care, vol. 30, no. 10, pp. 2529–2535, 2007.
- M. W. Wangh and D. Wang, “Study progress of the relationship between insulin resistance in type 2 diabetes mellitus and nitric oxide,” Medical Recapitulate, vol. 16, no. 8, pp. 1242–1244, 2010.
- L. Guo, M. Sun, D. Li, et al., “A preliminary study on the effects of high glucose and the leucocyte of diabetic patients on endothelial cells,” Chinese Journal of Geriatrics, vol. 24, no. 9, pp. 652–654, 2005.
- F. Cavalot, A. Petrelli, M. Traversa et al., “Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga diabetes study,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 3, pp. 813–819, 2006.
- K. Azuma, R. Kawamori, Y. Toyofuku et al., “Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 10, pp. 2275–2280, 2006.
- A. Ellis, Z. J. Cheng, Y. Li et al., “Effects of a Western diet versus high glucose on endothelium-dependent relaxation in murine micro- and macro-vasculature,” The European Journal of Pharmacology, vol. 601, no. 1–3, pp. 111–117, 2008.
- I. F. Benter, M. H. M. Yousif, J. T. Anim, C. Cojocel, and D. I. Diz, “Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME,” The American Journal of Physiology, vol. 290, no. 2, pp. H684–H691, 2006.
- A. Ceriello, J. Davidson, M. Hanefeld et al., “Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 16, no. 7, pp. 453–456, 2006.
- Z. Tang, “IGT and impaired endothelial dysfunction,” Internal Medicine in China, vol. 4, no. 1, pp. 108–111, 2009.
- M. Shimabukuro, N. Higa, N. Takasu, T. Tagawa, and S. Ueda, “A single dose of nateglinide improves post-challenge glucose metabolism and endothelial dysfunction in type 2 diabetic patients,” Diabetic Medicine, vol. 21, no. 9, pp. 983–986, 2004.
- T. Mita, H. Watada, T. Shimizu et al., “Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 11, pp. 2456–2462, 2007.